Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-08
2005-03-08
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S350000, C530S324000, C530S395000, C435S069100
Reexamination Certificate
active
06864235
ABSTRACT:
The present invention provides compositions and methods for treating a tissue disorder associated with a response-to-injury process or proliferating cells in a mammal. The tissue disorders include fibrosis, inflammation, degeneration and invasive disorders such as those occur in cancerous cells. The methods provided herein include administering to the mammal, an effective amount of a composition that alters the activity of transition molecules within a cell. Transition molecules are shown to be comprised of hyaladherins, hyaluronans and associated molecules that regulate the transitional phenotype.
REFERENCES:
patent: 4018884 (1977-04-01), Cleeland, Jr. et al.
patent: 4359535 (1982-11-01), Pieczenik
patent: 4376110 (1983-03-01), David et al.
patent: 4411993 (1983-10-01), Gillis
patent: 4486530 (1984-12-01), David et al.
patent: 4528266 (1985-07-01), Pieczenik
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: RE32011 (1985-10-01), Zimmerman et al.
patent: 4551433 (1985-11-01), DeBoer
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4744981 (1988-05-01), Pavanasasivam
patent: 4745051 (1988-05-01), Smith et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 4816597 (1989-03-01), Snyder, II et al.
patent: 4851341 (1989-07-01), Hopp et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4902614 (1990-02-01), Wakabayashi et al.
patent: 4987071 (1991-01-01), Cech et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5087571 (1992-02-01), Leder et al.
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5106951 (1992-04-01), Morgan, Jr. et al.
patent: 5110833 (1992-05-01), Mosbach
patent: 5162215 (1992-11-01), Bosselman et al.
patent: 5166057 (1992-11-01), Palese et al.
patent: 5169784 (1992-12-01), Summers et al.
patent: 5175383 (1992-12-01), Leder et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5204244 (1993-04-01), Fell et al.
patent: 5217879 (1993-06-01), Huang et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5221778 (1993-06-01), Byrne et al.
patent: 5225539 (1993-07-01), Winter
patent: 5242687 (1993-09-01), Tykocinski et al.
patent: 5243041 (1993-09-01), Fernandez-Pol
patent: 5254678 (1993-10-01), Haseloff et al.
patent: 5266317 (1993-11-01), Tomalski et al.
patent: 5288514 (1994-02-01), Ellman
patent: 5288641 (1994-02-01), Roizman
patent: 5328834 (1994-07-01), Ngo et al.
patent: 5347075 (1994-09-01), Sorge
patent: 5359051 (1994-10-01), Cook et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5395750 (1995-03-01), Dillon et al.
patent: 5463564 (1995-10-01), Agrafiotis et al.
patent: 5482856 (1996-01-01), Fell, Jr. et al.
patent: 5506337 (1996-04-01), Summerton et al.
patent: 5545808 (1996-08-01), Hew et al.
patent: 5567607 (1996-10-01), Zhao et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5591624 (1997-01-01), Barber et al.
patent: 5633076 (1997-05-01), DeBoer et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5698435 (1997-12-01), Robinson et al.
patent: 5716613 (1998-02-01), Guber et al.
patent: 5716826 (1998-02-01), Gruber et al.
patent: 5716832 (1998-02-01), Barber et al.
patent: 5741957 (1998-04-01), Deboer et al.
patent: 5770380 (1998-06-01), Hamilton et al.
patent: 5780009 (1998-07-01), Karatzas et al.
patent: 5780225 (1998-07-01), Wigler et al.
patent: 5789245 (1998-08-01), Dubensky, Jr. et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5817491 (1998-10-01), Yee et al.
patent: 5840479 (1998-11-01), Little et al.
patent: 5843723 (1998-12-01), Dubensky, Jr. et al.
patent: 5849288 (1998-12-01), Reisner
patent: 5851529 (1998-12-01), Guber et al.
patent: 5872005 (1999-02-01), Wang et al.
patent: 6271344 (2001-08-01), Turley
patent: 0415731 (1991-03-01), None
patent: 0440219 (1991-08-01), None
patent: 0612844 (1994-08-01), None
patent: 0 721 012 (1996-07-01), None
patent: 0360257 (1996-11-01), None
patent: 0 950 708 (1999-10-01), None
patent: Wo 8901973 (1989-03-01), None
patent: WO 9002809 (1990-03-01), None
patent: WO 9007862 (1990-07-01), None
patent: WO 9007936 (1990-07-01), None
patent: WO 9100285 (1991-01-01), None
patent: WO 9215677 (1992-09-01), None
patent: WO 9215679 (1992-09-01), None
patent: WO 9310218 (1993-05-01), None
patent: Wo 9311230 (1993-06-01), None
patent: WO 9312227 (1993-06-01), None
patent: WO 9320242 (1993-10-01), None
patent: WO9321312 (1993-10-01), None
patent: WO 9321312 (1993-10-01), None
patent: WO 9325234 (1993-12-01), None
patent: WO 9325698 (1993-12-01), None
patent: WO 9403622 (1994-02-01), None
patent: Wo 9206693 (1994-04-01), None
patent: WO 9502566 (1995-01-01), None
patent: WO 9504277 (1995-02-01), None
patent: WO 9510607 (1995-04-01), None
patent: Wo 9512387 (1995-05-01), None
patent: WO 9516209 (1995-06-01), None
patent: WO 9516712 (1995-06-01), None
patent: WO 9516918 (1995-06-01), None
patent: WO 9524186 (1995-09-01), None
patent: WO 9524929 (1995-09-01), None
patent: WO 9530642 (1995-11-01), None
patent: WO 9600148 (1996-01-01), None
patent: WO9738098 (1997-10-01), None
patent: WO 9738098 (1997-10-01), None
patent: Wo 9901164 (1999-01-01), None
patent: WO 0001841 (2000-01-01), None
patent: WO 0029447 (2000-05-01), None
patent: WO 0039166 (2000-07-01), None
patent: WO 0180899 (2001-11-01), None
patent: WO 0213848 (2002-02-01), None
patent: WO 0228415 (2002-04-01), None
Day, A. J. (2002) Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. vol. 277, pp. 4585-4588.*
Assmann, V. et al. (1999) The Intracellular hyraluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments J Cell Sci. vol. 112, pp. 3943-3954.*
William J. Kuhns et al., “Hyaluronic Acid-Receptor Binding Demonstrated by Synthetic Adhesive Proteoglycan Peptide Constructs and by Cell Receptors on the Marine Sponge Microciona prolifera,” Reports from the MBL General Scientific Meetings; Reference: Biol. Bull. 195: 216-218 (Oct. 1998).
Savani et al., “The Role of Hyaluronan and Its Receptors in restonosis After Balloon Angioplasty: Development of a Potential Therapy”, Inc. J. Tiss. Reac. XVII (4) pp. 141-151 (1995).
W.F. Cheung, “Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates call responses to growth factors”, Biochemical Society Transactions, pp. 135-142 (Feb. 1999).
U.S. Patent application Ser. No. 09/544,522, Turkey et al., filed Apr. 3, 2000.
Chao, et al., “The characterization of a human RHAMM cDNA: conservation of they hyaluronan-binding domains”,Gene, vol. 174, No. 2, (1996), pp. 299-306.
Jean, et al., “Unmasking a Hyaluronan-binding site of the BX7B type in the H3 heavy chain of the inter-alpha-Inhibitor family”,European Journal of Biochemistry, vol. 268, No. 3, (Feb. 1, 2001), pp. 544-553.
Volker, et al., “The human hyaluron receptor RHAMM is expressed as an intracellular protein in breast cancer cells”,J. Cell Science, vol. 111, (1998), pp. 1685-1694.
International Search Report of Aug. 22, 2001 in PCT Application No. PCT/I00/01534 (copending application).
Alting-Mees et al., “Monoclonal Antibody Expression Libraries: A Rapid Alternative to Hybridomas,”Strategies in Molecular Biology 3: 1-9, 1990.
Bauer et al., “A genetic enrichment for mutations constructed by oligodeoxynucleotide-directed mutagenesis,”Gene 37: 73-81, 1985.
Bird et al., “Single-Chain Antigen-Binding Proteins,”Science 242(4877): 423-426, 1988.
Brinster et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs,”PNAS 82(13): 4438-4442, Jul. 1985.
Chothia et al., “Domain Association in Immunoglobulin Molecules. The Packing of Variable Domains,”Journal of Molecular Biology 186(3): 651-663, 1985.
Craik et al., “Use of Oligonucleotides for Site-Specific Mutagenesis,”BioTechniques 3(1): 12-19, 1985.
Curiel et al.,
Cruz Tony F.
Turley Eva A.
Carlson Karen Cochrane
Fish & Richardson P.C.
Liu Samuel Wei
LandOfFree
Compositions and methods for treating cellular response to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating cellular response to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating cellular response to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436551